Preparation and preclinical evaluation of 64Cu-labeled prostate-specific membrane antigen (PSMA) probe for PET imaging of prostate cancer

被引:0
|
作者
Okarvi, Subhani [1 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Cyclotron & Radiopharmaceut Dept, Riyadh, Saudi Arabia
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
241662
引用
收藏
页数:2
相关论文
共 50 条
  • [1] 64Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer
    Banerjee, Sangeeta Ray
    Pullambhatla, Mrudula
    Foss, Catherine A.
    Nimmagadda, Sridhar
    Ferdani, Riccardo
    Anderson, Carolyn J.
    Mease, Ronnie C.
    Pomper, Martin G.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) : 2657 - 2669
  • [2] 64Cu-labeled inhibitors of prostate specific membrane antigen for PET imaging of prostate cancer
    Banerjee, Sangeeta R.
    Pullambhatla, Mrudula
    Byun, Youngjoo
    Foss, Catherine
    Nimmagadda, Sridhar
    Ferdani, Riccardo
    Anderson, Carolyn J.
    Mease, Ronnie C.
    Pomper, Martin G.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 : S369 - S369
  • [3] Preclinical evaluation of a 64Cu-labeled disintegrin for PET imaging of prostate cancer
    Hossein Jadvar
    Kai Chen
    Ryan Park
    Li-Peng Yap
    Ivetta Vorobyova
    Steve Swenson
    Francis S. Markland
    Amino Acids, 2019, 51 : 1569 - 1575
  • [4] Preclinical evaluation of a 64Cu-labeled disintegrin for PET imaging of prostate cancer
    Jadvar, Hossein
    Chen, Kai
    Park, Ryan
    Yap, Li-Peng
    Vorobyova, Ivetta
    Swenson, Steve
    Markland, Francis S.
    AMINO ACIDS, 2019, 51 (10-12) : 1569 - 1575
  • [5] Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer
    Feneley, MR
    Jan, H
    Granowska, M
    Mather, SJ
    Ellison, D
    Glass, J
    Coptcoat, M
    Kirby, RS
    Ogden, C
    Oliver, RTD
    Badenoch, DF
    Chinegwundoh, FI
    Nargund, VH
    Paris, AMI
    Britton, KE
    PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (01) : 47 - 52
  • [6] Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer
    MR Feneley
    H Jan
    M Granowska
    SJ Mather
    D Ellison
    J Glass
    M Coptcoat
    RS Kirby
    C Ogden
    RTD Oliver
    DF Badenoch
    FI Chinegwundoh
    VH Nargund
    AMI Paris
    KE Britton
    Prostate Cancer and Prostatic Diseases, 2000, 3 : 47 - 52
  • [7] Preclinical evaluation of a 68Ga- and 64Cu-labeled urea-based inhibitor of the prostate specific membrane antigen (PSMA). A promising diagnostic radiopharmaceutical for prostate cancer imaging.
    Gourni, Eleni
    Goncalves, Victor
    Denat, Franck
    Meyer, Phillip
    Maecke, Helmut R.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2015, 58 : S59 - S59
  • [8] Preparation and Initial Evaluation of 18F-labeled PSMA for Prostate Specific Membrane Antigen (PSMA) targeted PET imaging of Prostate Cancer
    Okarvi, S.
    AlJammaz, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S715 - S715
  • [9] Development and Initial Evaluation of 64Cu-Labeled Disintegrin for PET Imaging of Prostate Cancer
    Jadvar, Hossein
    Chen, Kai
    Park, Ryan
    Yap, Li-Peng
    Vorobyova, Ivetta
    Swenson, Steven
    Markland, Frank
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [10] 99mTc-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer
    Ray, Sangeeta
    Pullambhatla, Mrudula
    Falk, Alexander
    Byun, Youngjoo
    Foss, Catherine
    Nimmagadda, Sridhar
    Fox, James
    Mease, Ronnie
    Pomper, Martin
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52